Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiopulmonary Bypass | 38 | 2022 | 203 | 5.380 |
Why?
|
Heart Defects, Congenital | 43 | 2021 | 703 | 4.180 |
Why?
|
Cardiac Surgical Procedures | 35 | 2022 | 461 | 3.860 |
Why?
|
Aortic Valve | 15 | 2023 | 401 | 3.750 |
Why?
|
Aortic Valve Stenosis | 7 | 2023 | 295 | 3.440 |
Why?
|
Hypoplastic Left Heart Syndrome | 15 | 2021 | 112 | 2.500 |
Why?
|
Pulmonary Valve | 9 | 2020 | 99 | 2.010 |
Why?
|
Fontan Procedure | 10 | 2023 | 154 | 1.840 |
Why?
|
Ventricular Outflow Obstruction | 3 | 2022 | 36 | 1.730 |
Why?
|
Calcinosis | 4 | 2021 | 282 | 1.720 |
Why?
|
Extracorporeal Membrane Oxygenation | 11 | 2013 | 240 | 1.460 |
Why?
|
Pulmonary Artery | 20 | 2021 | 1063 | 1.390 |
Why?
|
Osteogenesis | 4 | 2018 | 213 | 1.310 |
Why?
|
Aorta | 9 | 2020 | 367 | 1.280 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2022 | 374 | 1.260 |
Why?
|
Heart Ventricles | 11 | 2023 | 727 | 1.210 |
Why?
|
Coronary Vessel Anomalies | 7 | 2016 | 29 | 1.190 |
Why?
|
Heart Septal Defects, Ventricular | 6 | 2022 | 43 | 1.190 |
Why?
|
Norwood Procedures | 5 | 2021 | 25 | 1.080 |
Why?
|
Hemodynamics | 17 | 2021 | 1004 | 1.050 |
Why?
|
Postoperative Complications | 27 | 2021 | 2235 | 1.030 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 3 | 2022 | 18 | 1.030 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 2 | 2023 | 52 | 1.000 |
Why?
|
Tetralogy of Fallot | 8 | 2021 | 79 | 0.930 |
Why?
|
Double Outlet Right Ventricle | 2 | 2022 | 10 | 0.930 |
Why?
|
Infant, Newborn | 45 | 2021 | 5255 | 0.910 |
Why?
|
Coronary Vessels | 2 | 2018 | 233 | 0.890 |
Why?
|
Heart Transplantation | 11 | 2023 | 671 | 0.880 |
Why?
|
Toll-Like Receptor 4 | 2 | 2016 | 330 | 0.870 |
Why?
|
Atrioventricular Block | 1 | 2022 | 33 | 0.860 |
Why?
|
Abnormalities, Multiple | 3 | 2019 | 181 | 0.810 |
Why?
|
Infant | 49 | 2022 | 8293 | 0.780 |
Why?
|
Heart Arrest | 4 | 2019 | 291 | 0.780 |
Why?
|
Transposition of Great Vessels | 2 | 2017 | 28 | 0.770 |
Why?
|
Humans | 140 | 2023 | 118974 | 0.770 |
Why?
|
Hemofiltration | 3 | 2013 | 31 | 0.760 |
Why?
|
Swine | 21 | 2022 | 730 | 0.680 |
Why?
|
Sinus of Valsalva | 4 | 2016 | 9 | 0.680 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2018 | 8 | 0.680 |
Why?
|
Ventricular Function, Left | 7 | 2023 | 468 | 0.670 |
Why?
|
Heart Valve Prosthesis | 6 | 2021 | 125 | 0.640 |
Why?
|
Treatment Outcome | 39 | 2022 | 9342 | 0.590 |
Why?
|
Aorta, Thoracic | 6 | 2021 | 248 | 0.590 |
Why?
|
Alkaline Phosphatase | 4 | 2019 | 157 | 0.580 |
Why?
|
Pulmonary Valve Stenosis | 2 | 2015 | 18 | 0.580 |
Why?
|
Intensive Care, Neonatal | 2 | 2008 | 42 | 0.560 |
Why?
|
Coronary Artery Disease | 2 | 2017 | 647 | 0.530 |
Why?
|
Aortic Diseases | 3 | 2022 | 94 | 0.530 |
Why?
|
Tachycardia, Ventricular | 3 | 2018 | 151 | 0.520 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 348 | 0.510 |
Why?
|
Male | 72 | 2021 | 57801 | 0.510 |
Why?
|
Coronavirus Infections | 1 | 2020 | 339 | 0.510 |
Why?
|
Sirolimus | 1 | 2016 | 195 | 0.510 |
Why?
|
Vascular Stiffness | 4 | 2020 | 425 | 0.500 |
Why?
|
Placental Circulation | 1 | 2014 | 56 | 0.500 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 189 | 0.490 |
Why?
|
Female | 71 | 2021 | 61565 | 0.480 |
Why?
|
Heart Valve Prosthesis Implantation | 6 | 2019 | 189 | 0.480 |
Why?
|
Animals, Newborn | 10 | 2009 | 806 | 0.480 |
Why?
|
Heart-Assist Devices | 2 | 2016 | 485 | 0.470 |
Why?
|
Autophagy | 1 | 2017 | 315 | 0.470 |
Why?
|
Tissue and Organ Procurement | 3 | 2022 | 248 | 0.460 |
Why?
|
Factor VIII | 1 | 2013 | 56 | 0.460 |
Why?
|
Internship and Residency | 2 | 2021 | 1001 | 0.450 |
Why?
|
Cesarean Section | 1 | 2014 | 165 | 0.450 |
Why?
|
Acute Kidney Injury | 4 | 2022 | 709 | 0.450 |
Why?
|
Child | 35 | 2023 | 19129 | 0.450 |
Why?
|
Retrospective Studies | 31 | 2022 | 12978 | 0.450 |
Why?
|
Systemic Inflammatory Response Syndrome | 3 | 2006 | 75 | 0.450 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 1440 | 0.450 |
Why?
|
Pandemics | 2 | 2022 | 1355 | 0.450 |
Why?
|
Cells, Cultured | 5 | 2023 | 4077 | 0.440 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 2445 | 0.440 |
Why?
|
Platelet Transfusion | 1 | 2013 | 68 | 0.440 |
Why?
|
Vascular Surgical Procedures | 3 | 2019 | 262 | 0.440 |
Why?
|
Hemolysis | 4 | 2016 | 174 | 0.430 |
Why?
|
Fibrinogen | 1 | 2013 | 161 | 0.430 |
Why?
|
Heart Valve Diseases | 6 | 2019 | 135 | 0.420 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2019 | 228 | 0.410 |
Why?
|
Proteomics | 2 | 2009 | 876 | 0.410 |
Why?
|
Patient Care Team | 2 | 2008 | 521 | 0.410 |
Why?
|
Magnetic Resonance Imaging | 12 | 2023 | 3174 | 0.410 |
Why?
|
Heart Arrest, Induced | 6 | 2016 | 32 | 0.370 |
Why?
|
Arterio-Arterial Fistula | 2 | 2013 | 4 | 0.360 |
Why?
|
Hypertrophy, Right Ventricular | 2 | 2020 | 146 | 0.360 |
Why?
|
Databases, Factual | 8 | 2013 | 1231 | 0.350 |
Why?
|
Time Factors | 19 | 2021 | 6412 | 0.350 |
Why?
|
Anesthesia | 1 | 2011 | 120 | 0.350 |
Why?
|
Suction | 2 | 1999 | 32 | 0.340 |
Why?
|
Heart Bypass, Right | 4 | 2018 | 15 | 0.340 |
Why?
|
Bioprosthesis | 4 | 2019 | 36 | 0.330 |
Why?
|
Life Support Care | 1 | 2008 | 27 | 0.330 |
Why?
|
Equipment Design | 7 | 2016 | 519 | 0.330 |
Why?
|
Oxygenators, Membrane | 2 | 2005 | 2 | 0.320 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 129 | 0.320 |
Why?
|
Oxygenators | 1 | 2008 | 4 | 0.320 |
Why?
|
Follow-Up Studies | 21 | 2021 | 4596 | 0.310 |
Why?
|
Tissue Donors | 2 | 2020 | 336 | 0.310 |
Why?
|
Complement C1 Inhibitor Protein | 1 | 2007 | 8 | 0.300 |
Why?
|
Centrifugation | 2 | 2013 | 31 | 0.300 |
Why?
|
Infant, Low Birth Weight | 1 | 2008 | 125 | 0.300 |
Why?
|
Forecasting | 2 | 2020 | 353 | 0.300 |
Why?
|
Child, Preschool | 25 | 2021 | 9491 | 0.300 |
Why?
|
Echocardiography, Transesophageal | 4 | 2012 | 89 | 0.290 |
Why?
|
Heart Septal Defects, Atrial | 4 | 2011 | 50 | 0.290 |
Why?
|
Signal Transduction | 4 | 2023 | 4709 | 0.290 |
Why?
|
Hematocrit | 3 | 2016 | 91 | 0.280 |
Why?
|
Endocarditis | 2 | 2021 | 33 | 0.280 |
Why?
|
Prosthesis Implantation | 1 | 2007 | 141 | 0.280 |
Why?
|
Hyperglycemia | 1 | 2010 | 312 | 0.280 |
Why?
|
Cause of Death | 2 | 2008 | 380 | 0.280 |
Why?
|
Inflammation | 7 | 2022 | 2566 | 0.270 |
Why?
|
Jugular Veins | 2 | 2019 | 47 | 0.270 |
Why?
|
Mitral Valve | 3 | 2014 | 91 | 0.270 |
Why?
|
Membranes, Artificial | 1 | 2005 | 70 | 0.260 |
Why?
|
Anastomosis, Surgical | 3 | 2021 | 146 | 0.260 |
Why?
|
Adolescent | 21 | 2021 | 18480 | 0.260 |
Why?
|
Mitral Valve Stenosis | 2 | 2014 | 21 | 0.260 |
Why?
|
Hospital Mortality | 8 | 2013 | 814 | 0.250 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 399 | 0.250 |
Why?
|
Coronary Aneurysm | 1 | 2004 | 11 | 0.240 |
Why?
|
Risk Factors | 16 | 2020 | 9000 | 0.240 |
Why?
|
Defibrillators, Implantable | 1 | 2007 | 299 | 0.240 |
Why?
|
Stroke Volume | 6 | 2020 | 513 | 0.240 |
Why?
|
Thymus Gland | 2 | 2021 | 300 | 0.240 |
Why?
|
Length of Stay | 9 | 2013 | 1032 | 0.240 |
Why?
|
Blood Coagulation Disorders | 1 | 2006 | 208 | 0.230 |
Why?
|
Animals | 26 | 2022 | 33381 | 0.230 |
Why?
|
Preoperative Care | 3 | 2018 | 332 | 0.230 |
Why?
|
Risk Assessment | 10 | 2018 | 3057 | 0.230 |
Why?
|
Endocarditis, Bacterial | 2 | 2021 | 37 | 0.230 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2017 | 157 | 0.230 |
Why?
|
Catheterization | 3 | 2013 | 163 | 0.230 |
Why?
|
Echocardiography | 6 | 2019 | 556 | 0.230 |
Why?
|
Cardiovascular Surgical Procedures | 3 | 2016 | 37 | 0.230 |
Why?
|
Palliative Care | 8 | 2019 | 629 | 0.230 |
Why?
|
Case-Control Studies | 6 | 2021 | 3171 | 0.230 |
Why?
|
Random Allocation | 5 | 2009 | 344 | 0.230 |
Why?
|
Extracorporeal Circulation | 2 | 2000 | 15 | 0.230 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2016 | 181 | 0.230 |
Why?
|
Hypertension, Pulmonary | 7 | 2021 | 1794 | 0.220 |
Why?
|
Middle Aged | 19 | 2021 | 27617 | 0.220 |
Why?
|
Registries | 2 | 2008 | 1810 | 0.210 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 1795 | 0.210 |
Why?
|
Oxylipins | 1 | 2022 | 28 | 0.210 |
Why?
|
Methylprednisolone | 2 | 2000 | 84 | 0.210 |
Why?
|
Adenosine Triphosphatases | 1 | 2023 | 158 | 0.210 |
Why?
|
Ultrafiltration | 2 | 2016 | 28 | 0.210 |
Why?
|
Terminology as Topic | 2 | 2000 | 211 | 0.210 |
Why?
|
Probability | 3 | 2009 | 305 | 0.210 |
Why?
|
Intraoperative Complications | 2 | 2010 | 132 | 0.200 |
Why?
|
Marfan Syndrome | 2 | 2018 | 42 | 0.200 |
Why?
|
Brain Injuries | 1 | 2006 | 484 | 0.200 |
Why?
|
Truncus Arteriosus | 1 | 2020 | 5 | 0.200 |
Why?
|
Adult | 20 | 2020 | 31512 | 0.190 |
Why?
|
Blood Glucose | 1 | 2010 | 1939 | 0.190 |
Why?
|
Postoperative Care | 2 | 2012 | 237 | 0.190 |
Why?
|
Endothelium, Vascular | 4 | 2006 | 907 | 0.180 |
Why?
|
Heart Rate | 5 | 2013 | 729 | 0.180 |
Why?
|
Cerebrovascular Circulation | 5 | 2004 | 204 | 0.180 |
Why?
|
Survival Rate | 7 | 2018 | 1720 | 0.180 |
Why?
|
Reference Values | 3 | 2009 | 774 | 0.180 |
Why?
|
Thrombocytopenia | 1 | 2021 | 185 | 0.170 |
Why?
|
Blotting, Western | 2 | 2021 | 1194 | 0.170 |
Why?
|
Infant, Newborn, Diseases | 1 | 2020 | 106 | 0.170 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 185 | 0.170 |
Why?
|
Prospective Studies | 13 | 2019 | 6471 | 0.170 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2018 | 7 | 0.170 |
Why?
|
Receptors, Complement | 3 | 2006 | 115 | 0.170 |
Why?
|
Thrombophilia | 1 | 1999 | 68 | 0.170 |
Why?
|
Autografts | 1 | 2019 | 49 | 0.170 |
Why?
|
Heart Function Tests | 3 | 2009 | 61 | 0.170 |
Why?
|
Aprotinin | 2 | 2010 | 9 | 0.170 |
Why?
|
Models, Cardiovascular | 1 | 2020 | 180 | 0.170 |
Why?
|
Postoperative Hemorrhage | 1 | 1999 | 79 | 0.170 |
Why?
|
Societies, Medical | 4 | 2008 | 703 | 0.170 |
Why?
|
Lung | 7 | 2022 | 3664 | 0.160 |
Why?
|
Cattle | 4 | 2019 | 978 | 0.160 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2018 | 90 | 0.160 |
Why?
|
Turner Syndrome | 1 | 2018 | 50 | 0.160 |
Why?
|
Endotoxemia | 1 | 2019 | 93 | 0.160 |
Why?
|
Blood Flow Velocity | 5 | 2020 | 327 | 0.160 |
Why?
|
Ultrasonography, Prenatal | 3 | 2014 | 227 | 0.160 |
Why?
|
Cardiac Care Facilities | 1 | 2017 | 14 | 0.160 |
Why?
|
Graft Rejection | 4 | 2021 | 555 | 0.160 |
Why?
|
Age Factors | 8 | 2014 | 2995 | 0.160 |
Why?
|
Endotoxins | 1 | 2019 | 234 | 0.160 |
Why?
|
Ultrasonography, Interventional | 2 | 2010 | 155 | 0.160 |
Why?
|
Fibrinolysis | 1 | 1999 | 159 | 0.160 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2018 | 72 | 0.150 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 285 | 0.150 |
Why?
|
Surgery, Computer-Assisted | 2 | 2008 | 69 | 0.150 |
Why?
|
Milrinone | 2 | 2013 | 27 | 0.150 |
Why?
|
Fatal Outcome | 3 | 2014 | 287 | 0.150 |
Why?
|
Arterial Occlusive Diseases | 2 | 2012 | 74 | 0.150 |
Why?
|
Cardiac Catheterization | 3 | 2018 | 541 | 0.150 |
Why?
|
Cryosurgery | 1 | 2018 | 54 | 0.150 |
Why?
|
Coronary Angiography | 3 | 2013 | 311 | 0.150 |
Why?
|
Oxygen | 6 | 2005 | 854 | 0.150 |
Why?
|
Comorbidity | 2 | 2020 | 1527 | 0.150 |
Why?
|
Tachycardia | 2 | 2014 | 48 | 0.150 |
Why?
|
Hemostasis | 3 | 2016 | 70 | 0.150 |
Why?
|
Heart Aneurysm | 1 | 1996 | 10 | 0.150 |
Why?
|
Pulmonary Valve Insufficiency | 2 | 2019 | 36 | 0.150 |
Why?
|
Primary Cell Culture | 1 | 2017 | 155 | 0.150 |
Why?
|
beta Catenin | 1 | 2018 | 219 | 0.140 |
Why?
|
Curriculum | 2 | 2021 | 910 | 0.140 |
Why?
|
Creatinine | 1 | 2018 | 491 | 0.140 |
Why?
|
Magnetic Resonance Imaging, Cine | 3 | 2023 | 154 | 0.140 |
Why?
|
Anesthetics | 1 | 2016 | 58 | 0.140 |
Why?
|
Aneurysm, False | 1 | 1996 | 46 | 0.140 |
Why?
|
Program Development | 2 | 2016 | 357 | 0.140 |
Why?
|
Down Syndrome | 3 | 2010 | 356 | 0.140 |
Why?
|
Organ Sparing Treatments | 1 | 2016 | 31 | 0.140 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 188 | 0.140 |
Why?
|
Survival Analysis | 4 | 2021 | 1267 | 0.140 |
Why?
|
Specialty Boards | 1 | 2016 | 39 | 0.140 |
Why?
|
Aged | 9 | 2021 | 19657 | 0.130 |
Why?
|
Aortic Aneurysm | 1 | 2016 | 51 | 0.130 |
Why?
|
Immunoblotting | 1 | 2016 | 307 | 0.130 |
Why?
|
Research Design | 2 | 2020 | 969 | 0.130 |
Why?
|
Cardiac Output, Low | 1 | 1995 | 68 | 0.130 |
Why?
|
Anti-Inflammatory Agents | 1 | 1999 | 465 | 0.130 |
Why?
|
Elastin | 1 | 2015 | 77 | 0.130 |
Why?
|
Logistic Models | 4 | 2014 | 1901 | 0.130 |
Why?
|
Equipment Failure Analysis | 2 | 2013 | 139 | 0.130 |
Why?
|
Certification | 1 | 2016 | 99 | 0.130 |
Why?
|
Incidence | 4 | 2018 | 2424 | 0.130 |
Why?
|
Specialties, Surgical | 1 | 2016 | 76 | 0.130 |
Why?
|
RNA | 1 | 2021 | 833 | 0.130 |
Why?
|
T-Lymphocytes | 2 | 2021 | 1774 | 0.120 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 525 | 0.120 |
Why?
|
Echocardiography, Doppler | 1 | 2014 | 95 | 0.120 |
Why?
|
United States | 12 | 2013 | 12555 | 0.120 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2014 | 53 | 0.120 |
Why?
|
Tricuspid Atresia | 1 | 2013 | 7 | 0.120 |
Why?
|
Pulmonary Circulation | 4 | 2008 | 424 | 0.120 |
Why?
|
Altitude | 1 | 2018 | 422 | 0.120 |
Why?
|
Coronary Circulation | 2 | 2020 | 121 | 0.120 |
Why?
|
Brain | 4 | 2019 | 2490 | 0.120 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 1995 | 121 | 0.120 |
Why?
|
Vasodilator Agents | 4 | 2013 | 328 | 0.120 |
Why?
|
Reoperation | 5 | 2021 | 557 | 0.120 |
Why?
|
Deglutition Disorders | 1 | 1995 | 131 | 0.120 |
Why?
|
Blood Vessel Prosthesis | 3 | 2016 | 115 | 0.120 |
Why?
|
Young Adult | 5 | 2020 | 10793 | 0.120 |
Why?
|
Image Enhancement | 1 | 2014 | 181 | 0.120 |
Why?
|
Transplantation, Homologous | 5 | 2021 | 415 | 0.120 |
Why?
|
Blalock-Taussig Procedure | 1 | 2013 | 3 | 0.110 |
Why?
|
Patient Handoff | 1 | 2013 | 27 | 0.110 |
Why?
|
Blood Coagulation Factors | 2 | 2006 | 43 | 0.110 |
Why?
|
Hospital Rapid Response Team | 1 | 2013 | 15 | 0.110 |
Why?
|
Proteins | 3 | 2009 | 938 | 0.110 |
Why?
|
Heart | 1 | 2017 | 631 | 0.110 |
Why?
|
Biopsy | 1 | 2016 | 1079 | 0.110 |
Why?
|
Hospital Costs | 3 | 1998 | 110 | 0.110 |
Why?
|
Pericardium | 1 | 2012 | 50 | 0.110 |
Why?
|
Ligation | 2 | 2009 | 82 | 0.110 |
Why?
|
Hemorrhage | 1 | 2016 | 623 | 0.110 |
Why?
|
Quality Improvement | 2 | 2017 | 963 | 0.110 |
Why?
|
Postoperative Period | 1 | 2013 | 309 | 0.110 |
Why?
|
Operating Rooms | 1 | 2013 | 90 | 0.110 |
Why?
|
Coronary Sinus | 1 | 2012 | 7 | 0.110 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 1597 | 0.110 |
Why?
|
Vascular Resistance | 6 | 1999 | 356 | 0.110 |
Why?
|
Biomarkers | 3 | 2017 | 3588 | 0.100 |
Why?
|
Gestational Age | 1 | 2014 | 765 | 0.100 |
Why?
|
Thoracic Surgical Procedures | 1 | 2012 | 64 | 0.100 |
Why?
|
Lung Diseases | 3 | 2016 | 718 | 0.100 |
Why?
|
Evaluation Studies as Topic | 2 | 2011 | 182 | 0.100 |
Why?
|
Ventricular Function, Right | 3 | 2020 | 257 | 0.100 |
Why?
|
Arteriovenous Fistula | 1 | 2012 | 29 | 0.100 |
Why?
|
Heart Septum | 2 | 2010 | 28 | 0.100 |
Why?
|
Propensity Score | 1 | 2013 | 242 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2007 | 736 | 0.100 |
Why?
|
Severity of Illness Index | 4 | 2011 | 2674 | 0.100 |
Why?
|
Cohort Studies | 6 | 2021 | 5116 | 0.100 |
Why?
|
Confidence Intervals | 2 | 2011 | 324 | 0.100 |
Why?
|
Hospitals, Pediatric | 2 | 2011 | 505 | 0.100 |
Why?
|
Heart Diseases | 2 | 2008 | 341 | 0.100 |
Why?
|
Heart Atria | 2 | 2010 | 112 | 0.100 |
Why?
|
Anticoagulants | 2 | 2006 | 559 | 0.100 |
Why?
|
Purines | 2 | 2022 | 161 | 0.090 |
Why?
|
Hypothermia, Induced | 3 | 2000 | 68 | 0.090 |
Why?
|
Mediastinitis | 1 | 2010 | 2 | 0.090 |
Why?
|
Colorado | 5 | 2020 | 4196 | 0.090 |
Why?
|
Sternotomy | 1 | 2010 | 11 | 0.090 |
Why?
|
Odds Ratio | 4 | 2018 | 996 | 0.090 |
Why?
|
Blood Pressure | 6 | 2005 | 1664 | 0.090 |
Why?
|
Recurrent Laryngeal Nerve Injuries | 1 | 2009 | 4 | 0.090 |
Why?
|
Hemostatics | 1 | 2010 | 50 | 0.090 |
Why?
|
Academies and Institutes | 1 | 2010 | 44 | 0.090 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2020 | 41 | 0.090 |
Why?
|
Vocal Cord Paralysis | 1 | 2009 | 23 | 0.090 |
Why?
|
Systole | 2 | 2020 | 168 | 0.090 |
Why?
|
Body Weight | 2 | 2011 | 934 | 0.090 |
Why?
|
Vascular Malformations | 1 | 2010 | 47 | 0.090 |
Why?
|
Apoptosis | 1 | 2019 | 2484 | 0.090 |
Why?
|
Statistics, Nonparametric | 2 | 2008 | 403 | 0.090 |
Why?
|
Blood Transfusion | 2 | 2016 | 306 | 0.090 |
Why?
|
Prognosis | 4 | 2011 | 3443 | 0.090 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2009 | 50 | 0.080 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 106 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2013 | 635 | 0.080 |
Why?
|
Emergencies | 1 | 2010 | 153 | 0.080 |
Why?
|
Continuity of Patient Care | 1 | 2011 | 265 | 0.080 |
Why?
|
Clinical Competence | 1 | 2016 | 951 | 0.080 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2010 | 158 | 0.080 |
Why?
|
Tissue and Organ Harvesting | 1 | 2009 | 67 | 0.080 |
Why?
|
Transducers | 1 | 2008 | 27 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 277 | 0.080 |
Why?
|
Nitric Oxide | 4 | 1999 | 892 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2010 | 150 | 0.080 |
Why?
|
Metabolome | 2 | 2021 | 296 | 0.080 |
Why?
|
Disease Models, Animal | 2 | 2009 | 3730 | 0.080 |
Why?
|
Infusions, Intravenous | 2 | 2007 | 380 | 0.080 |
Why?
|
Canada | 2 | 2010 | 340 | 0.080 |
Why?
|
North America | 1 | 2008 | 266 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 1995 | 772 | 0.080 |
Why?
|
Pregnancy | 3 | 2014 | 5691 | 0.080 |
Why?
|
Respiratory Function Tests | 2 | 2007 | 526 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 1945 | 0.080 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2012 | 38 | 0.080 |
Why?
|
Electrodes, Implanted | 1 | 2007 | 97 | 0.070 |
Why?
|
Multicenter Studies as Topic | 1 | 2008 | 253 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2010 | 521 | 0.070 |
Why?
|
Disease Management | 1 | 2011 | 571 | 0.070 |
Why?
|
Gastroesophageal Reflux | 1 | 2009 | 248 | 0.070 |
Why?
|
Aptamers, Peptide | 1 | 2006 | 5 | 0.070 |
Why?
|
Factor VII | 1 | 2006 | 24 | 0.070 |
Why?
|
Receptor, PAR-1 | 1 | 2006 | 21 | 0.070 |
Why?
|
Factor VIIa | 1 | 2006 | 36 | 0.070 |
Why?
|
Consensus | 1 | 2008 | 534 | 0.070 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2006 | 35 | 0.070 |
Why?
|
Brain Ischemia | 2 | 2000 | 310 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2008 | 325 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2006 | 119 | 0.070 |
Why?
|
Complement Inactivating Agents | 1 | 2006 | 43 | 0.070 |
Why?
|
Coated Materials, Biocompatible | 1 | 2006 | 58 | 0.070 |
Why?
|
Antifibrinolytic Agents | 1 | 2006 | 44 | 0.070 |
Why?
|
Electrocardiography | 3 | 2014 | 556 | 0.070 |
Why?
|
Isotonic Solutions | 1 | 2005 | 43 | 0.070 |
Why?
|
Blood Gas Analysis | 1 | 2005 | 69 | 0.070 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2005 | 14 | 0.070 |
Why?
|
Blood Component Transfusion | 1 | 2006 | 84 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2008 | 294 | 0.070 |
Why?
|
Communication | 1 | 2011 | 761 | 0.070 |
Why?
|
Data Collection | 1 | 2008 | 658 | 0.070 |
Why?
|
Equipment Contamination | 1 | 2005 | 55 | 0.070 |
Why?
|
Factor Xa Inhibitors | 1 | 2006 | 138 | 0.070 |
Why?
|
Punctures | 2 | 2010 | 39 | 0.070 |
Why?
|
alpha-Macroglobulins | 1 | 2005 | 24 | 0.070 |
Why?
|
Hospitals | 1 | 2010 | 598 | 0.060 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2009 | 325 | 0.060 |
Why?
|
Birth Weight | 1 | 2008 | 465 | 0.060 |
Why?
|
Vena Cava, Superior | 1 | 2004 | 21 | 0.060 |
Why?
|
Prosthesis Design | 2 | 2019 | 285 | 0.060 |
Why?
|
Aspirin | 1 | 2007 | 334 | 0.060 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2004 | 5 | 0.060 |
Why?
|
Stents | 2 | 2001 | 457 | 0.060 |
Why?
|
Cardiomyopathy, Dilated | 2 | 1999 | 344 | 0.060 |
Why?
|
Complement Inactivator Proteins | 1 | 2004 | 39 | 0.060 |
Why?
|
Sepsis | 1 | 2010 | 531 | 0.060 |
Why?
|
Models, Animal | 1 | 2005 | 363 | 0.060 |
Why?
|
Materials Testing | 1 | 2005 | 359 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2023 | 1868 | 0.060 |
Why?
|
Cardiotonic Agents | 2 | 2012 | 127 | 0.060 |
Why?
|
In Vitro Techniques | 1 | 2005 | 1094 | 0.060 |
Why?
|
DiGeorge Syndrome | 1 | 2003 | 21 | 0.060 |
Why?
|
Suture Techniques | 2 | 2016 | 134 | 0.060 |
Why?
|
Echocardiography, Stress | 1 | 2003 | 21 | 0.060 |
Why?
|
Hemoglobins | 1 | 2005 | 326 | 0.060 |
Why?
|
Catheterization, Central Venous | 1 | 2004 | 95 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2006 | 502 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2006 | 1308 | 0.050 |
Why?
|
International Cooperation | 2 | 2000 | 177 | 0.050 |
Why?
|
Prevalence | 3 | 2020 | 2326 | 0.050 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2005 | 613 | 0.050 |
Why?
|
Lung Transplantation | 2 | 2006 | 263 | 0.050 |
Why?
|
Europe | 2 | 2000 | 356 | 0.050 |
Why?
|
Lung Compliance | 2 | 1999 | 49 | 0.050 |
Why?
|
Prostaglandins | 1 | 2022 | 78 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2010 | 1166 | 0.050 |
Why?
|
Pulmonary Gas Exchange | 2 | 1999 | 117 | 0.050 |
Why?
|
Regional Blood Flow | 2 | 2021 | 418 | 0.050 |
Why?
|
Transplantation, Autologous | 2 | 2003 | 191 | 0.050 |
Why?
|
Thoracic Surgery | 2 | 2000 | 120 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2004 | 546 | 0.050 |
Why?
|
Candida parapsilosis | 1 | 2021 | 4 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2004 | 272 | 0.050 |
Why?
|
Filtration | 2 | 2000 | 64 | 0.050 |
Why?
|
Tryptophan | 1 | 2022 | 139 | 0.050 |
Why?
|
Practice Patterns, Physicians' | 1 | 2010 | 1200 | 0.050 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2001 | 10 | 0.050 |
Why?
|
Ventricular Dysfunction | 1 | 2001 | 15 | 0.050 |
Why?
|
Myocardial Contraction | 2 | 2020 | 339 | 0.050 |
Why?
|
Niacinamide | 1 | 2021 | 70 | 0.050 |
Why?
|
Kynurenine | 1 | 2021 | 81 | 0.050 |
Why?
|
Myocardium | 2 | 2023 | 970 | 0.050 |
Why?
|
Waiting Lists | 1 | 2022 | 228 | 0.050 |
Why?
|
Methionine | 1 | 2021 | 145 | 0.050 |
Why?
|
Exercise Test | 1 | 2003 | 551 | 0.050 |
Why?
|
Organ Transplantation | 1 | 2003 | 165 | 0.050 |
Why?
|
Surveys and Questionnaires | 2 | 2020 | 4708 | 0.050 |
Why?
|
Gene Transfer Techniques | 1 | 2001 | 154 | 0.050 |
Why?
|
Renal Circulation | 1 | 2000 | 75 | 0.050 |
Why?
|
North Carolina | 3 | 2012 | 109 | 0.050 |
Why?
|
Brain Death | 1 | 2020 | 29 | 0.050 |
Why?
|
Pulmonary Atresia | 1 | 1999 | 7 | 0.050 |
Why?
|
Patient-Specific Modeling | 1 | 2020 | 37 | 0.050 |
Why?
|
Spin Labels | 1 | 2000 | 50 | 0.050 |
Why?
|
Plasma Substitutes | 1 | 1999 | 4 | 0.050 |
Why?
|
Protective Agents | 1 | 2000 | 42 | 0.040 |
Why?
|
Blood Substitutes | 1 | 2000 | 28 | 0.040 |
Why?
|
Diterpenes | 1 | 1999 | 31 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2000 | 88 | 0.040 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 1999 | 43 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 1384 | 0.040 |
Why?
|
Nitrogen Oxides | 1 | 2000 | 56 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2001 | 749 | 0.040 |
Why?
|
Genetic Therapy | 1 | 2001 | 267 | 0.040 |
Why?
|
Elective Surgical Procedures | 1 | 2020 | 160 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 180 | 0.040 |
Why?
|
Diastole | 1 | 2019 | 145 | 0.040 |
Why?
|
Academic Medical Centers | 2 | 2013 | 422 | 0.040 |
Why?
|
Death | 1 | 2020 | 105 | 0.040 |
Why?
|
History, 21st Century | 1 | 2020 | 170 | 0.040 |
Why?
|
Thromboplastin | 1 | 1999 | 68 | 0.040 |
Why?
|
Lactones | 1 | 1999 | 57 | 0.040 |
Why?
|
Pulmonary Veins | 1 | 2000 | 84 | 0.040 |
Why?
|
Time | 1 | 2019 | 77 | 0.040 |
Why?
|
Perfusion Imaging | 1 | 2019 | 44 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 842 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 409 | 0.040 |
Why?
|
History, 20th Century | 1 | 2020 | 281 | 0.040 |
Why?
|
Leukocytes | 1 | 2000 | 290 | 0.040 |
Why?
|
Morbidity | 2 | 2010 | 296 | 0.040 |
Why?
|
Linear Models | 2 | 2011 | 827 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2012 | 1125 | 0.040 |
Why?
|
Cineangiography | 1 | 1997 | 17 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 1999 | 200 | 0.040 |
Why?
|
Biomechanical Phenomena | 1 | 2020 | 683 | 0.040 |
Why?
|
Antibodies | 1 | 2000 | 392 | 0.040 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 229 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 1999 | 367 | 0.040 |
Why?
|
Infant Mortality | 1 | 2018 | 94 | 0.040 |
Why?
|
Quality of Health Care | 2 | 2013 | 586 | 0.040 |
Why?
|
Cardiology Service, Hospital | 1 | 1997 | 29 | 0.040 |
Why?
|
Kidney | 2 | 2022 | 1353 | 0.040 |
Why?
|
Respiration, Artificial | 2 | 2013 | 545 | 0.040 |
Why?
|
Surgical Wound Infection | 2 | 2010 | 251 | 0.040 |
Why?
|
Point-of-Care Systems | 1 | 1999 | 151 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 1999 | 238 | 0.040 |
Why?
|
Dipyridamole | 1 | 1997 | 27 | 0.040 |
Why?
|
Nitric Oxide Synthase | 1 | 1998 | 225 | 0.040 |
Why?
|
Edema | 1 | 1998 | 124 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1998 | 290 | 0.040 |
Why?
|
Metabolomics | 1 | 2021 | 550 | 0.040 |
Why?
|
Brachiocephalic Trunk | 1 | 2016 | 11 | 0.040 |
Why?
|
Safety | 1 | 1998 | 304 | 0.040 |
Why?
|
Replantation | 1 | 2016 | 29 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2012 | 2436 | 0.030 |
Why?
|
Aortic Valve Insufficiency | 1 | 2016 | 42 | 0.030 |
Why?
|
Ischemia | 1 | 1999 | 374 | 0.030 |
Why?
|
Organ Size | 2 | 2012 | 460 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2021 | 767 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2000 | 545 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2021 | 963 | 0.030 |
Why?
|
Isoproterenol | 1 | 1995 | 125 | 0.030 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 1995 | 10 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 1998 | 554 | 0.030 |
Why?
|
Sternum | 1 | 1994 | 17 | 0.030 |
Why?
|
Computer Systems | 1 | 2014 | 47 | 0.030 |
Why?
|
Adenosine | 1 | 1996 | 211 | 0.030 |
Why?
|
Pyridones | 1 | 1995 | 119 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 1996 | 209 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 1798 | 0.030 |
Why?
|
Weight Gain | 1 | 1998 | 493 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 1995 | 120 | 0.030 |
Why?
|
Kinetics | 1 | 2017 | 1624 | 0.030 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 1995 | 119 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2021 | 1753 | 0.030 |
Why?
|
Streptococcal Infections | 1 | 1996 | 141 | 0.030 |
Why?
|
Truncus Arteriosus, Persistent | 1 | 2013 | 6 | 0.030 |
Why?
|
Magnetics | 1 | 2013 | 38 | 0.030 |
Why?
|
Chronic Disease | 2 | 1998 | 1636 | 0.030 |
Why?
|
Airway Extubation | 1 | 2013 | 45 | 0.030 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2012 | 33 | 0.030 |
Why?
|
Calcitonin | 1 | 2012 | 29 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2013 | 148 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2013 | 133 | 0.030 |
Why?
|
Staphylococcal Infections | 1 | 1996 | 346 | 0.030 |
Why?
|
Protein Precursors | 1 | 2012 | 126 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2012 | 203 | 0.030 |
Why?
|
Hypoxia | 1 | 1998 | 963 | 0.030 |
Why?
|
Ultrasonography | 1 | 1995 | 716 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2012 | 649 | 0.020 |
Why?
|
Heart Septal Defects | 1 | 2010 | 10 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2012 | 210 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2012 | 360 | 0.020 |
Why?
|
Dyspnea | 1 | 2012 | 201 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 70 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 2012 | 226 | 0.020 |
Why?
|
Live Birth | 1 | 2010 | 47 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2013 | 225 | 0.020 |
Why?
|
Disease Progression | 2 | 2011 | 2490 | 0.020 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2010 | 18 | 0.020 |
Why?
|
Databases as Topic | 1 | 2010 | 73 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2011 | 238 | 0.020 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2009 | 15 | 0.020 |
Why?
|
Mitral Valve Insufficiency | 1 | 2010 | 62 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 195 | 0.020 |
Why?
|
Program Evaluation | 1 | 2013 | 845 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 2009 | 170 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2010 | 178 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2011 | 1474 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2008 | 164 | 0.020 |
Why?
|
Oxygen Consumption | 2 | 2000 | 586 | 0.020 |
Why?
|
Hospitals, University | 2 | 1997 | 172 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2009 | 247 | 0.020 |
Why?
|
Critical Care | 1 | 2010 | 492 | 0.020 |
Why?
|
Densitometry | 1 | 2005 | 30 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2005 | 113 | 0.020 |
Why?
|
Metalloproteases | 1 | 2005 | 38 | 0.020 |
Why?
|
Pediatrics | 1 | 2013 | 985 | 0.020 |
Why?
|
Mice | 1 | 2021 | 15520 | 0.020 |
Why?
|
Blood Specimen Collection | 1 | 2004 | 34 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2004 | 43 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2004 | 41 | 0.020 |
Why?
|
Angioplasty | 1 | 2004 | 39 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2005 | 215 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2005 | 249 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2004 | 87 | 0.010 |
Why?
|
Capillary Permeability | 1 | 2004 | 140 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2005 | 306 | 0.010 |
Why?
|
Syndrome | 1 | 2004 | 344 | 0.010 |
Why?
|
Rest | 1 | 2003 | 104 | 0.010 |
Why?
|
Immunity | 1 | 2003 | 129 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 2001 | 25 | 0.010 |
Why?
|
Quality of Life | 1 | 2012 | 2366 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 872 | 0.010 |
Why?
|
Physical Endurance | 1 | 2003 | 231 | 0.010 |
Why?
|
Immune System | 1 | 2003 | 181 | 0.010 |
Why?
|
Intraoperative Period | 1 | 2001 | 55 | 0.010 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2001 | 44 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2001 | 65 | 0.010 |
Why?
|
Exercise Tolerance | 1 | 2003 | 233 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 4552 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2001 | 334 | 0.010 |
Why?
|
Adenoviridae | 1 | 2001 | 191 | 0.010 |
Why?
|
Cyclic N-Oxides | 1 | 2000 | 31 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2001 | 302 | 0.010 |
Why?
|
Ginkgolides | 1 | 1999 | 4 | 0.010 |
Why?
|
Ventilators, Mechanical | 1 | 2000 | 47 | 0.010 |
Why?
|
Bronchiolitis Obliterans | 1 | 2000 | 66 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2000 | 185 | 0.010 |
Why?
|
Actin Cytoskeleton | 1 | 2000 | 100 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2003 | 1067 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2003 | 632 | 0.010 |
Why?
|
Perfusion | 1 | 1999 | 153 | 0.010 |
Why?
|
Antibody Formation | 1 | 2000 | 276 | 0.010 |
Why?
|
Microcirculation | 1 | 1999 | 155 | 0.010 |
Why?
|
Pulmonary Edema | 1 | 1999 | 125 | 0.010 |
Why?
|
Acetylcholine | 1 | 1999 | 208 | 0.010 |
Why?
|
Radiography | 1 | 2001 | 861 | 0.010 |
Why?
|
Immunization | 1 | 2000 | 412 | 0.010 |
Why?
|
Cytokines | 1 | 2005 | 1900 | 0.010 |
Why?
|
Protein Conformation | 1 | 2000 | 848 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1997 | 202 | 0.010 |
Why?
|
Oregon | 1 | 1996 | 69 | 0.010 |
Why?
|
Recovery of Function | 1 | 2000 | 604 | 0.010 |
Why?
|
Drug Combinations | 1 | 1997 | 291 | 0.010 |
Why?
|
Gene Expression | 1 | 2001 | 1489 | 0.010 |
Why?
|
Edema, Cardiac | 1 | 1994 | 4 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1996 | 656 | 0.010 |
Why?
|
Calcium | 1 | 2000 | 1169 | 0.010 |
Why?
|
Coronary Disease | 1 | 1996 | 356 | 0.010 |
Why?
|
Recurrence | 1 | 1996 | 975 | 0.010 |
Why?
|
Liver | 1 | 2001 | 1816 | 0.010 |
Why?
|
Survivors | 1 | 1996 | 418 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 1996 | 6561 | 0.000 |
Why?
|